Evonik offers bond buyback for retail investors
- Partial buyback of Evonik Degussa bonds enters second phase
- Special offer for retail investors with fixed buyback price of 105,316%
- Transaction intended to reduce debt and to smoothen the maturity profile
After the first quotation phase retail investors now have a special opportunity to sell their shares of the Evonik Degussa bonds back to Evonik Industries at a fixed price of 105,316%.
From October 21 to November 9, 2011, 5:00 p.m. (Frankfurt/Main local time), retail investors holding shares with nominal values of less than €250,000 may offer these securities to Evonik Industries for a buyback through their regular financial institutions.
"We think this offer is both interesting and fair. Retail investors and the company will benefit from this buyback," notes Chief Financial Officer, Dr. Wolfgang Colberg.
Interested investors may contact their regular financial institutions or the Evonik homepage at www.evonik.com.
Outside of the Federal Republic of Germany, the Netherlands, Austria, and Luxembourg the information contained in this press release neither represents an offer to purchase securities nor a request to issue a sales quotation and shall not be deemed to target persons who are prohibited or not permitted to receive such request.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.
Evonik Industries AG
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. In 2010 about 80 percent of the Group's chemicals sales came from activities where it ranks among the market leaders. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world. In fiscal 2010 more than 34,000 employees generated sales of around €13.3 billion and an operating profit (EBITDA) of about €2.4 billion.